These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20522090)

  • 1. Neuroimaging and cognition in Parkinson's disease dementia.
    Silbert LC; Kaye J
    Brain Pathol; 2010 May; 20(3):646-53. PubMed ID: 20522090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.
    Gomperts SN; Marquie M; Locascio JJ; Bayer S; Johnson KA; Growdon JH
    Neurodegener Dis; 2016; 16(1-2):118-24. PubMed ID: 26655867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobiology of cognitive impairment in Parkinson's disease.
    Jellinger KA
    Expert Rev Neurother; 2012 Dec; 12(12):1451-66. PubMed ID: 23237352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.
    Borroni B; Premi E; Formenti A; Turrone R; Alberici A; Cottini E; Rizzetti C; Gasparotti R; Padovani A
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1049-55. PubMed ID: 26109553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.
    Petrou M; Dwamena BA; Foerster BR; MacEachern MP; Bohnen NI; Müller ML; Albin RL; Frey KA
    Mov Disord; 2015 Jun; 30(7):928-35. PubMed ID: 25879534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive conditions of pathologically confirmed dementia with Lewy bodies and Parkinson's disease with dementia.
    Horimoto Y; Matsumoto M; Nakazawa H; Yuasa H; Morishita M; Akatsu H; Ikari H; Yamamoto T; Kosaka K
    J Neurol Sci; 2003 Dec; 216(1):105-8. PubMed ID: 14607310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease.
    Goldmann Gross R; Siderowf A; Hurtig HI
    Neurosignals; 2008; 16(1):24-34. PubMed ID: 18097157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers.
    Tröster AI
    Neuropsychol Rev; 2008 Mar; 18(1):103-19. PubMed ID: 18322801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Parkinson syndrome and cognitive disorders].
    Szirmai I; Kovács T
    Ideggyogy Sz; 2002 Jul; 55(7-8):220-5. PubMed ID: 12201229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment in Parkinson's disease and dementia with Lewy bodies.
    Aarsland D
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S144-8. PubMed ID: 26411499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
    van der Zee S; Vermeiren Y; Fransen E; Van Dam D; Aerts T; Gerritsen MJ; Spikman JM; van Laar T; De Deyn PP
    J Parkinsons Dis; 2018; 8(1):71-84. PubMed ID: 29480224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment in Parkinson's disease.
    Cosgrove J; Alty JE; Jamieson S
    Postgrad Med J; 2015 Apr; 91(1074):212-20. PubMed ID: 25814509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.
    Christopher L; Strafella AP
    J Neuropsychol; 2013 Sep; 7(2):225-40. PubMed ID: 23551844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluctuating cognition and different cognitive and behavioural profiles in Parkinson's disease with dementia: comparison of dementia with Lewy bodies and Alzheimer's disease.
    Varanese S; Perfetti B; Monaco D; Thomas A; Bonanni L; Tiraboschi P; Onofrj M
    J Neurol; 2010 Jun; 257(6):1004-11. PubMed ID: 20094726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI and cognitive impairment in Parkinson's disease.
    Ibarretxe-Bilbao N; Tolosa E; Junque C; Marti MJ
    Mov Disord; 2009; 24 Suppl 2():S748-53. PubMed ID: 19877242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias.
    Fields JA
    Arch Clin Neuropsychol; 2017 Nov; 32(7):786-801. PubMed ID: 28961866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.